News

The genome incorporation mechanism for LINE-1, the only autonomously active retrotransposon in humans, leverages the cell ...
A first-in-human clinical trial tests a CRISPR/Cas9 gene-editing technique to help the immune system fight advanced gastrointestinal (GI) cancers.
Scientists identified broadly neutralizing antitoxin antibodies in blood from snake venom-exposed hyperimmune donor for ...
Researchers say GlycoCaging may offer a route to rescue promising drug candidates that currently show unacceptable systemic ...
Accurate genomic profiling is essential for clinical decision-making and optimizing treatment recommendations.
Researchers say that while a new study has implications for neurodegenerative disease research, its more immediate impact ...
Scientists from the Keck School of Medicine at University of Southern California have developed a spectral flow ...
Thermo Fisher will provide upstream expansion of hMSCs and downstream purification of MSCs and MSC-derived exosomes, and drug ...
Researchers have identified a potential strategy to protect against Alzheimer’s by increasing the clusterin (CLU) protein, ...
Utilizing a filamentous fungus in the gut microbiome may provide a new strategy for treating metabolic dysfunction-associated ...
Merck KGaA said the deal will grow its U.S. presence and expand the reach of SpringWorks’ drugs, including one approved in ...
A potential strategy introduces an entirely new type of therapy capable of addressing previously ‘undruggable’ targets within ...